REDHILL BIOPHARMA LTD Chart calendar RedHill Biopharma Ltd
daddafadeb5e10c1774.8kpufm2cyXOPD24oqRM5AvdII3Kkmp1Gc6iH2oIZMSg.hwMiFCf5mh-8QFZl_n56WoMDQRWQ2_sIRM3KvsBedn69OiQYNfWOKv9JDQ~a3e320e2e8373da2dc43e530aa9e160b
Upcoming events on RedHill Biopharma Ltd
Past events on RedHill Biopharma Ltd
| 2024-04-08 09:23 am | Q4 2023 Earnings Release |
| 2023-08-17 07:00 am | Q2 2023 Earnings Release |
| 2023-06-12 08:00 am | Q1 2023 Earnings Release |
| 2023-05-04 11:00 am | Aegis Capital Corp Virtual Conference |
| 2023-04-28 07:00 am | Q4 2022 Earnings Release |
| 2022-11-29 08:00 am | Q3 2022 Earnings Release |
| 2022-11-20 | International Conference on Microbiology & Infectious Diseases |
| 2022-10-20 | American College of Gastroenterology Scientific Meeting - Poster No - A089 |
| 2022-10-20 | American College of Gastroenterology Scientific Meeting - Poster No - A090 |
| 2022-10-20 | American College of Gastroenterology Scientific Meeting - Poster No - A0683 |
| 2022-08-16 | Talicia® -World Gastro Congress |
| 2022-08-06 | International Conference on Emerging Infectious Diseases |
| 2022-07-12 | ARDS Drug Development Summit |
| 2022-06-23 08:30 am | Q1 2022 Earnings Call |
| 2022-06-23 07:00 am | Q1 2022 Earnings Release |
| 2022-05-22 | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-20 | Digestive Diseases Week Conference - Poster Number: Tu1078 |
| 2022-05-20 | Digestive Diseases Week Conference - poster number: Tu1077 |
| 2022-05-12 08:00 am | Annual General Meeting |
| 2022-03-28 | Cantor Fitzgerald Virtual Rare Orphan Disease Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,29 6,88 -8.55% | 64,4 68,1 -5.54% | 85,8 87,9 -2.44% | 61,8 68,0 -9.12% |
|
EBITDA Million USD | Released Forecast Spread | -42,2 -40,2 -5.05% | -54,9 -48,0 -14.46% | -69,0 -66,0 -4.56% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -43,2 -42,1 -2.5% | -63,7 -49,9 -27.6% | -81,1 -78,1 -3.92% | -42,8 -29,7 -44.26% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -42,3 -41,3 -2.37% | -76,2 -65,3 -16.73% | -97,7 -95,0 -2.93% | -71,7 -41,1 -74.38% |
|
Net income Million USD | Released Forecast Spread | -42,3 -41,3 -2.37% | -76,2 -65,3 -16.73% | -97,7 -95,0 -2.93% | -71,7 -41,1 -74.38% |
|
EPS USD | Released Forecast Spread | -56,0 -35,3 -58.73% | -84,0 -46,6 -80.41% | -84,0 -39,5 -112.43% | -1,20 -2,80 57.14% |
| Announcement Date | 04/03/20 | 18/03/21 | 17/03/22 | 28/04/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22,1 24,1 -8.37% | 18,2 23,6 -22.73% | 18,3 21,5 -14.68% | 17,6 18,5 -5.12% | 12,8 18,1 -29.29% |
|
EBITDA Million USD | Released Forecast Spread | -18,4 -15,4 -19.32% | -10,4 -14,4 27.81% | |||
|
EBIT Million USD | Released Forecast Spread | -20,7 -17,6 -17.5% | -13,2 -15,1 12.33% | -9,16 -6,89 -32.93% | -7,11 -4,20 -69.24% | -9,95 0,30 -3416% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,4 -22,0 -10.8% | -17,1 -17,6 2.63% | -11,7 -10,6 -10.4% | -35,7 -7,50 -376.01% | -3,73 -1,40 -166.36% |
|
Net income Million USD | Released Forecast Spread | -24,4 -22,0 -10.8% | -17,1 -17,6 2.63% | -11,7 -10,6 -10.4% | -35,7 -7,50 -376.01% | -3,73 -1,40 -166.36% |
|
EPS USD | Released Forecast Spread | -20,0 -8,34 -139.73% | -1,20 -1,20 0% | -0,80 -0,60 -33.33% | -2,40 -0,40 -500% | 0,00 0,00 - |
| Announcement Date | 17/03/22 | 23/06/22 | 07/11/22 | 29/11/22 | 28/04/23 |
More events
